Holen Sie sich die Stockscreener-App
19.76
0.41%
0.08
Handel nachbörslich:
19.74
-0.02
-0.10%
Bausch Lomb Corp Aktie (BLCO) Neueste Nachrichten
Bausch + Lomb Co. (NYSE:BLCO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs - Business Wire
Bausch + Lomb (BLCO) Posts Impressive Revenue and Explores Potential Sale - Nasdaq
Bausch & Lomb Secures $400 Million in New Term Loans - Investing.com India
Bausch & Lomb Secures $400 Million in New Term Loans By Investing.com - Investing.com South Africa
Bausch + Lomb Corporation (NYSE:BLCO) Q3 2024 Earnings Call Transcript - Insider Monkey
Bausch & Lomb stock target lifted, keeps buy on strong Q3 results - Investing.com
Bausch + Lomb (BLCO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Bausch + Lomb (BLCO) Q3 Earnings and Revenues Top Estimates - Yahoo Finance
Orthokeratology Lens Market is expected to Double Its Size - openPR
Bausch + Lomb posts top-line beat, raises full-year outlook - Investing.com
Bausch + Lomb: Q3 Earnings Snapshot - Marketscreener.com
Bausch + Lomb Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Bausch + Lomb Announces Third-Quarter 2024 Results - Business Wire
Bausch & Lomb Corp (TSX:BLCO) Q3 2024 Earnings Report Preview: W - GuruFocus.com
BAUSCH & LOMB CORP (BLCO)Sunday, Jul 28, 2024 - Smartkarma
Dry Eye Treatment Market to Hit $9.3 Billion: Bausch + Lomb Acquires XIIDRA, New FDA Approvals Boost Options - openPR
Bausch + Lomb price target raised to $23 from $20 at RBC Capital - Yahoo Finance
Bausch + Lomb (BLCO) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
RBC raises Bausch & Lomb stock price target ahead of Q3 results - Investing.com Canada
Bausch + Lomb (NYSE:BLCO) PT Raised to $23.00 - MarketBeat
Banks, Private Credit Vie for $5 Billion Bausch + Lomb Debt - Bloomberg
Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags - Benzinga
Bausch & Lomb gains amid report TPG, Blackstone working on joint bid - MSN
Banks, Private Credit Vie for $5 Billion Bausch Lomb Financing | Today News - Mint
Exclusive | Bausch Health Rejects Bondholders’ Debt Proposals, Explores Sale of Vision Care UnitWSJ - The Wall Street Journal
Bausch & Lomb shares upgraded, price target raised By Investing.com - Investing.com UK
NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday - MSN
Bausch + Lomb Corp [BLCO] Investment Guide: What You Need to Know - Knox Daily
Why Bausch + Lomb Stock Soared by Over 7% on Monday - Yahoo Finance
TPG and Blackstone team up to bid for eyecare group Bausch + Lomb - Financial Times
Anthony Wallace of Bausch + Lomb talks about enVista Envy FDA approval - Ophthalmology Times
Bausch + Lomb wins FDA nod for enVista Envy range of intraocular lenses - Medical Device Network
Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid - Yahoo Finance
Bausch + Lomb (NYSE:BLCO) Sets New 1-Year HighHere's What Happened - MarketBeat
Bausch + Lomb stock hits 52-week high at $21.19 amid robust growth - Investing.com UK
S&P 500 Futures Rise in Premarket Trading; Bausch + Lomb, MicroStrategy Lead - Barron's
Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens - Business Wire
Bausch Lomb Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
A History of Outperforming Analyst Forecasts and Beating the Odds: Bausch + Lomb Corp (BLCO) - SETE News
Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30 - Business Wire
Marshall Wace LLP Takes $1.91 Million Position in Bausch + Lomb Co. (NYSE:BLCO) - MarketBeat
Bausch + Lomb eyes new ecommerce opportunity - Digital Commerce 360
Bausch + Lomb price target raised to $19 from $17 at Evercore ISI - Yahoo Finance
Bausch + Lomb Launches Opal™ Digital Marketplace in the United States - Business Wire
Clearline Capital LP Acquires 411,404 Shares of Bausch + Lomb Co. (NYSE:BLCO) - MarketBeat
Wall Street SWOT: Bausch + Lomb stock rides wave of eye health innovation - Investing.com
Bausch + Lomb Co. (NYSE:BLCO) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Epinephrine Autoinjectors Industry Research Business Report 2024 Featuring ALK-Abello, Bausch + Lomb, Emerade, Teva Pharmaceutical - Yahoo Finance
Bausch Health: A Buyout Bid Could Be The Ticket To Unlock Value - Barchart
Gabelli Funds LLC Purchases 78,000 Shares of Bausch + Lomb Co. (NYSE:BLCO) - MarketBeat
Here's Why Bausch Health Stock Gained 14.7% In A Week - Barchart
2.70%
3.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):